Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Patrick Rossignol
ResearcherPublications, citations & collaboration network
Patrick Rossignol is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 471 works, 17,433 citations, an h-index of 66 and an i10-index of 246.
471
Works
17,433
Citations
66
h-index
246
i10-index
How has Patrick Rossignol's publication output changed over time?
ScholarIQpublication output · 2009–2020
Output grew100% over the shown period — from 1 works in 2009 to 2 in 2020.
1
1
1
1
2
4
2
2009201220152017201820192020
What are the most-cited papers on Patrick Rossignol?
ScholarIQmost cited works
The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology
Wilfried Müllens, Kevin Damman, Veli‐Pekka Harjola, Alexandre Mebazaa, Hans‐Peter Brunner‐La Rocca, Pieter Martens, Jeffrey M. Testani, W.H. Wilson Tang, Francesco Orso, Patrick Rossignol, Marco Metra, Gerasimos Filippatos, Petar Seferović, Frank Ruschitzka, Andrew J.S. Coats
European Journal of Heart Failure. 20191,091 CitationsOPEN ACCESS
Chronic Kidney Disease and Coronary Artery Disease
Mark J. Sarnak, Kerstin Amann, Sripal Bangalore, João L. Cavalcante, David M. Charytan, Jonathan C. Craig, John S. Gill, Mark A. Hlatky, Alan G. Jardine, Ulf Landmesser, L. Kristin Newby, Charles A. Herzog, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer, Thomas H. Marwick, Debasish Banerjee, Carlo Briguori, Tara I. Chang, Chien‐Liang Chen, Christopher R. deFilippi, Xiaoqiang Ding, Charles J. Ferro, Jagbir Gill, Mario Gössl, Nicole M. Isbel, Hideki Ishii, Meg Jardine, Philip A. Kalra, Günther Laufer, Krista L. Lentine, Kevin W. Lobdell, Charmaine E. Lok, Gérard M. London, Jolanta Małyszko, Patrick B. Mark, Mohamed Marwan, Yuxin Nie, Patrick S. Parfrey, Roberto Pecoits‐Filho, Helen Pilmore, Wajeh Y. Qunibi, Paolo Raggi, Marcello Rattazzi, Patrick Rossignol, Josiah Ruturi, Charumathi Sabanayagam, Catherine M. Shanahan, Gautam R. Shroff, Rukshana Shroff, Angela C Webster, Daniel E. Weiner, Simon Winther, Alexander C. Wiseman, Anthony Yip, Alexander Zarbock
Journal of the American College of Cardiology. 2019738 CitationsOPEN ACCESS
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Andrew A. House, Christoph Wanner, Mark J. Sarnak, Ileana L. Piña, Christopher W. McIntyre, Paul Komenda, Bertram L. Kasiske, Anita Deswal, Christopher R. deFilippi, John G.F. Cleland, Stefan D. Anker, Charles A. Herzog, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer, Peter A. McCullough, Ali K. Abu‐Alfa, Kerstin Amann, Kazutaka Aonuma, Lawrence J. Appel, Colin Baigent, George L. Bakris, Debasish Banerjee, John Boletis, Biykem Bozkurt, Javed Butler, Christopher T. Chan, Maria Rosa Costanzo, Ruth F. Dubin, Gerasimos Filippatos, Betty Muthoni Gikonyo, Dan Gikonyo, Roger J. Hajjar, Kunitoshi Iseki, Hideki Ishii, Greg Knoll, Colin R. Lenihan, Krista L. Lentine, Edgar V. Lerma, Etienne Macedo, Patrick B. Mark, Eisei Noiri, Alberto Palazzuoli, Roberto Pecoits‐Filho, Bertram Pitt, Claudio Rigatto, Patrick Rossignol, Soko Setoguchi, Manish M. Sood, Stefan Störk, Rita S. Suri, Karolina Szummer, Sydney Tang, Navdeep Tangri, Aliza Thompson, Krishnaswami Vijayaraghavan, Michael D. Walsh, Angela Yee‐Moon Wang, Matthew R. Weir
Kidney International. 2019445 CitationsOPEN ACCESS
Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology
Wilfried Müllens, Kevin Damman, Jeffrey M. Testani, Pieter Martens, Christian Mueller, Johan Lassus, W.H. Wilson Tang, Hadi Skouri, Frederik H. Verbrugge, Francesco Orso, Loreena Hill, Dilek Ural, M Lainscak, Patrick Rossignol, Marco Metra, Alexandre Mebazaa, Petar Seferović, Frank Ruschitzka, Andrew J.S. Coats
European Journal of Heart Failure. 2020400 CitationsOPEN ACCESS
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal, Patrick Rossignol, Alain Romero, Dahlia Garza, Martha Mayo, Suzette Warren, Jia Ma, William B. White, Bryan Williams
The Lancet. 2019371 CitationsOPEN ACCESS
Related on ScholarIQ
Inserm
Institution
The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology
Paper
Chronic Kidney Disease and Coronary Artery Disease
Paper
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Paper
Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology
Paper
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Paper